kawasaki
diseas
kd
multisystem
vascul
primarili
affect
coronari
arteri
young
children
number
epidemiolog
clinic
observ
suggest
kd
caus
infecti
agent
suggest
rang
staphylococci
streptococci
mycoplasma
chlamydia
virus
adenoviru
parvoviru
epsteinbarr
viru
howev
singl
caus
pathogen
consist
demonstr
nasopharynx
oropharynx
skin
faec
patient
kd
intern
tissu
airway
gastrointestin
gi
tract
may
also
entri
colon
site
potenti
caus
agent
investig
detail
intens
interest
recent
center
novel
human
coronaviru
messeng
rna
mrna
detect
respiratori
secret
children
kd
howev
investig
abl
confirm
find
hypothes
mucosa
upper
gi
tract
could
involv
kd
role
gi
tract
immunolog
organ
constantli
expos
microorgan
agent
previous
observ
increas
number
cell
human
leucocyt
antigen
hla
dr
cell
fewer
cell
gut
patient
kd
compar
control
consequ
carri
microbiolog
investig
small
intestin
show
rang
bacteri
speci
adher
lumen
jejunum
patient
kd
quit
differ
control
notabl
five
strain
streptococci
two
strain
staphylococci
speci
known
common
sourc
superantigen
sag
isol
kd
patient
also
investig
tcellreceptor
tcr
express
small
intestin
u
n
l
g
r
g
n
l
r
c
l
e
mucosa
kd
patient
found
cell
select
increas
mucosa
patient
acut
phase
kd
compar
control
basi
find
carri
microbiolog
molecular
biolog
studi
focus
biolog
activ
microorgan
detect
alimentari
tract
surfac
kd
children
acut
phase
diseas
focus
particular
heat
shock
protein
hsp
superantigen
activ
view
previou
data
indic
might
role
kd
materi
method
studi
receiv
ethic
approv
juntendo
univers
hospit
tokyo
famili
patient
control
subject
given
consent
particip
studi
nineteen
patient
kd
boy
five
girl
month
year
age
enrol
studi
februari
june
diagnos
made
accord
clinic
criteria
kd
tabl
hospit
within
day
onset
fever
patient
except
one
patient
receiv
intraven
cglobulin
dose
gkg
coronari
arteri
involv
demonstr
patient
giant
aneur
found
patient
die
myocardi
infarct
patient
evid
persist
cardiac
abnorm
lesion
assess
echocardiographi
jejun
swab
specimen
peripher
blood
sampl
taken
analysi
kd
subject
control
patient
foodsensit
enteropathi
remiss
consid
control
subject
normal
popul
respect
jejun
microflora
reason
state
previou
studi
microbiolog
studi
jejun
surfac
swab
specimen
jejun
surfac
acquir
piec
jejun
mucosa
taken
use
steril
paediatr
crosbytyp
capsul
detail
microbiolog
examin
given
elsewher
none
subject
control
treat
antibiot
jejun
biopsi
taken
bacteria
cultur
brainheart
infus
medium
hr
bacteri
cultur
supernat
bc
collect
centrifug
filter
pore
membran
remov
bacteria
blood
sampl
taken
subject
kd
acut
phase
drug
treatment
day
onset
fever
ie
convalesc
phase
blood
specimen
children
foodsensit
enteropathi
convalesc
phase
taken
simultan
biopsi
peripher
blood
mononuclear
cell
cocultur
bc
peripher
blood
mononuclear
cell
pbmc
isol
blood
sampl
use
standard
procedur
densitygradi
centrifug
contain
pbmc
transfer
triplic
well
roundbottom
plate
becton
dickinson
franklin
lake
nj
incub
hr
carbon
dioxid
presenc
absenc
bc
final
concentr
screen
presenc
hsp
bc
bcsinduc
prolif
activ
pbmc
obtain
convalescentphas
kd
patient
compar
pbmc
control
hsp
could
induc
signific
cellprolif
activ
howev
cellprolif
activ
appear
weaker
induc
sag
potenti
immunodomin
protein
signific
cellprolif
activ
bc
contain
hsp
pbmc
defin
stimulatori
index
si
flow
cytometr
analysi
superantigen
activ
analysi
bc
describ
previous
look
expans
cell
tcell
prolifer
kd
patient
report
previous
cell
known
expand
clinic
isol
streptococcu
pyogen
toxin
use
posit
control
monoclon
antibodi
mab
obtain
pharmingen
san
diego
ca
data
analyz
use
cellquest
softwar
becton
dickinson
san
jose
ca
order
detect
bacteri
hsp
bc
human
endogen
hsp
molecul
pbmc
supernat
cocultur
bc
comparison
control
western
blot
analysi
perform
use
plasma
sampl
subject
antibodi
protein
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
carri
gel
atto
corpor
tokyo
japan
describ
previous
protein
bc
sampl
separ
sdspage
electrotransf
immobilon
p
polyvinyliden
difluorid
membran
millipor
billerica
membran
incub
min
dilut
plasma
sampl
obtain
patient
acut
convalesc
phase
kd
control
protein
visual
stain
coomassi
brilliant
blue
target
protein
excis
gel
trypsin
analyz
use
matrixassist
laser
desorpt
timeofflight
mass
spectromet
voyag
de
pro
appli
biosystem
tokyo
japan
list
correct
mass
peak
provid
detail
peptid
mass
fingerprint
pmf
protein
identifi
nation
center
biotechnolog
inform
ncbi
databas
pmf
use
msfit
program
protein
prospector
http
prospectorucsfedu
measur
concentr
cytokin
human
endogen
pbmc
cocultur
bc
enzymelink
immunosorb
assay
elisa
perform
use
mab
accord
manufactur
instruct
elisa
kit
interferonc
ifnc
tumour
necrosi
factora
tnfa
purchas
sanquin
research
amsterdam
netherland
human
endogen
obtain
stressgen
ann
arbor
mi
detect
limit
iuml
ifnc
pgml
tnfa
pgml
ngml
absorb
read
nm
air
use
micropl
reader
biorad
hercul
ca
pair
student
ttest
use
analyz
statist
signific
subject
kd
control
valu
p
consid
signific
detect
hsp
bc
bcsinduc
prolif
activ
pbmc
perform
bacteria
isol
kd
patient
gave
cultur
supernat
induc
signific
prolif
activ
si
autolog
pbmc
tabl
perform
antibioticsensit
test
strain
produc
bc
caus
signific
prolifer
pbmc
consid
possibl
treatment
bacteria
particip
onset
diseas
found
resist
commonli
use
antibiot
tabl
strain
bacteria
isol
control
children
produc
bc
induc
signific
prolif
activ
autolog
pbmc
determin
superantigen
activ
pbmc
stimul
bc
express
tcr
determin
cultur
cell
streptococcu
sanguini
kd
patient
streptococcu
orali
patient
streptococcu
miti
patient
staphylococc
strain
patient
produc
expans
tcell
popul
express
fig
none
strain
includ
neisseria
mucosa
induc
select
vb
expans
tcell
popul
children
kd
control
antibodi
respons
bacteri
product
induc
signific
prolif
activ
shown
tabl
host
plasma
analyz
western
blot
use
plasma
obtain
patient
acut
convalesc
stage
kd
plasma
sampl
obtain
patient
convalesc
stage
kd
treatment
immunoglobulin
show
vigor
antibodi
reactiv
molecular
weight
mw
protein
seen
acut
plasma
howev
interestingli
phenomenon
observ
blackwel
publish
ltd
immunolog
bc
origin
superantigen
strain
small
quantiti
mw
protein
seen
plasma
patient
acut
phase
kd
fig
b
furthermor
control
plasma
sampl
reactiv
seen
bacteri
product
origin
jejun
mucosa
control
kd
patient
lack
blood
sampl
imposs
examin
combin
therefor
repres
reactiv
pattern
sever
sampl
demonstr
fig
mw
target
protein
identifi
ncbi
databas
pmf
use
msfit
program
identifi
origin
organ
high
sequenc
coverag
tabl
interestingli
molecul
deriv
gramneg
strain
bacteria
kd
patient
wherea
gramposit
cocci
yield
hsp
other
alreadi
secret
onset
kd
frequent
detect
protein
hitherto
report
deriv
neisseria
spp
convalesc
plasma
patient
kd
previous
suggest
increas
express
endogen
hsp
may
contribut
abnorm
activ
immun
system
kd
patient
via
molecular
mimicri
bacteri
hsp
human
hsp
demonstr
product
endogen
hsp
pbmc
react
strain
bacteria
presenc
human
pbmc
cultur
supernat
cocultur
bc
induc
signific
prolif
activ
investig
elisa
product
endogen
clearli
evid
supernat
origin
gramneg
microb
compar
gramneg
microb
control
fig
analyz
homolog
deriv
bacteria
neisseria
acinetobact
human
endogen
accord
ncbi
databas
clustalw
w
multipl
sequenc
align
manufactur
refer
homolog
amino
acid
sequenc
bacteri
origin
n
mucosa
acinetobact
iwoffii
amino
acid
sequenc
human
presum
recogn
effector
cell
diseas
found
shown
tabl
indic
crossreact
figur
evalu
endogen
human
heat
shock
protein
produc
peripher
blood
mononuclear
cell
pbmc
cocultur
bacteri
cultur
supernat
bc
significantli
higher
content
endogen
determin
enzymelink
immunosorb
assay
elisa
found
supernat
origin
gramneg
strain
gramposit
strain
control
contain
small
amount
human
two
molecul
relat
possibl
pathogen
role
hspspecif
cell
kd
likewis
high
homolog
observ
amino
acid
sequenc
bacteri
amino
acid
sequenc
human
demonstr
bind
specif
similarli
amino
acid
sequenc
bacteri
amino
acid
sequenc
human
show
homolog
known
show
high
bind
affin
cytokin
respons
pbmc
bacteri
product
show
proinflammatori
cytokin
ifnc
tnfa
elicit
patient
kd
control
fig
recent
report
propos
increas
level
induc
molecul
could
lead
antiinflammatori
process
children
juvenil
idiopath
arthriti
also
investig
concentr
supernat
interestingli
microbi
product
except
sag
elicit
significantli
higher
respons
pbmc
kd
unlik
control
postul
primari
caus
kd
infecti
agent
elicit
cytokin
secret
cytokin
target
vascular
endotheli
cell
produc
cellsurfac
neoantigen
antibodi
produc
antigen
may
target
vascular
endothelium
result
cascad
event
lead
vascular
damag
search
aetiolog
agent
kd
carri
singl
infecti
agent
howev
plausibl
underli
principl
cooper
differ
mechan
differ
caus
bacteria
final
common
pathway
immun
activ
respons
clinic
disord
complic
recent
issu
rais
whether
provok
antigen
kd
might
conven
interferonc
ifnc
tumour
necrosi
factora
tnfa
product
induc
bc
obtain
signific
strain
control
supernat
p
versu
control
p
valu
omit
figur
tidi
view
microbi
product
except
superantigen
sag
elicit
significantli
higher
respons
pbmc
patient
kawasaki
diseas
unlik
control
p
tional
antigen
sag
although
debat
continu
regard
mechan
initi
immun
activ
like
scenario
sag
convent
peptid
antigen
work
togeth
direct
persist
immun
respons
lead
coronari
arteri
damag
unifi
model
propos
microb
superantigen
activ
initi
massiv
activ
develop
immun
system
subpopul
sagrespons
cell
rescu
apoptosi
result
interact
costimulatori
signal
antigenpres
cell
convent
peptid
antigen
peptid
antigen
may
deriv
infecti
mimic
immun
respons
perpetu
local
selfantigen
found
coronari
vessel
term
current
studi
provid
data
consist
two
hypothes
name
bacteria
uniqu
upper
bowel
patient
kd
sag
activ
supernat
bacteria
contain
hsp
induc
tcell
divis
product
proinflammatori
cytokin
one
may
concern
descript
orali
sanguini
miti
superantigen
strain
gener
known
superantigen
strain
report
sag
activ
miti
publish
sag
activ
orali
sanguini
yet
confirm
except
interest
find
suggest
possibl
toxic
shocklik
syndrom
caus
viridan
streptococci
strain
belong
sagrel
toxigen
convers
streptococcu
speci
howev
find
directli
support
product
sag
strain
investig
respect
obvious
requir
autolog
pbmc
may
problemat
cell
bear
certain
tcr
would
stimul
oligoclon
manner
would
eventu
becom
anerg
howev
demonstr
pbmc
obtain
patient
convalesc
phase
kd
capac
respond
sag
probabl
tcell
subset
bear
anerg
cell
never
expos
sag
young
children
reason
ifnc
tnfa
product
induc
bc
contain
sag
markedli
higher
induc
bc
without
sag
may
explain
likewis
hand
cell
respond
sag
convalesc
sampl
could
produc
moder
high
amount
cytokin
previou
theori
propos
signal
mediat
tcell
activ
tolllik
receptor
antigenpres
cell
includ
gi
dendrit
cell
although
also
report
contrari
heat
shock
protein
molecul
may
also
function
convent
peptid
antigen
attract
concept
crossreact
specif
epitop
bacteri
human
hsp
could
play
role
vascular
damag
characterist
kd
humor
cellular
reactiv
describ
common
vascular
diseas
atherosclerosi
may
share
common
pathogen
mechan
involv
immun
respons
howev
etiolog
agent
produc
bacteri
hsp
lead
onset
kd
unknown
identifi
possibl
aetiolog
pathogen
elucid
pathogen
mechan
focus
microbiota
produc
hsp
present
gi
tract
surfac
children
acut
kd
basi
find
obtain
previou
studi
agent
demonstr
rich
varieti
consist
hypothesi
mani
differ
agent
may
relat
onset
kd
base
find
studi
like
candid
bacteria
associ
pathogenesi
might
gramneg
microb
n
mucosa
cooper
plural
gramposit
cocci
superantigen
activ
furthermor
bacteri
seem
possess
certain
homolog
togeth
selfhsp
recent
studi
suggest
interact
bacteri
selfhsp
antibodi
respons
nonself
epitop
might
promot
concomit
gener
antiinflammatori
cytokin
induc
selfepitop
accumul
evid
epidemiolog
immunopatholog
studi
suggest
autoantibodi
crossreact
bacteri
may
induc
cytotox
damag
stress
endotheli
cell
result
coronari
atherosclerosi
theori
seem
applic
pathogenesi
coronari
lesion
kd
view
high
express
endotheli
cell
togeth
serolog
detect
bacteri
selfhsp
kd
patient
demonstr
investig
vascular
surfaceexpress
transfer
cytoplasm
mitochondria
follow
induct
bacteri
stimul
recogn
circul
antihsp
autoantibodi
cytotox
lymphocyt
target
autoantigen
incid
rate
coronari
lesion
patient
kd
may
depend
upon
strongli
caus
agent
induc
initi
immun
activ
elicit
autoreact
cell
importantli
much
selfhsp
molecul
evok
cytoplasm
mitochondria
vascular
surfac
interestingli
gramneg
microb
appear
trigger
selfhsp
gramposit
cocci
furthermor
gramneg
microb
n
mucosa
coexist
gramposit
cocci
isol
kd
patient
vascular
involv
amino
acid
sequenc
neisseria
found
studi
high
homolog
respect
core
epitop
protein
high
capabl
bind
human
class
ii
molecul
respect
sequenc
demonstr
high
affin
respect
drpeptid
bind
assay
interestingli
dr
allel
frequent
found
specif
japanes
popul
respect
may
account
high
incid
kd
among
japanes
peopl
explan
suggest
tolllik
receptor
hsp
polymorph
affect
product
control
selfhsp
autoantigen
includ
children
foodsensit
enteropathi
control
howev
entir
clear
whether
appropri
control
type
studi
may
inevit
limit
nearli
imposs
conduct
agematch
healthi
control
ethic
reason
immunoglobulin
help
acut
phase
ill
failur
rate
approxim
advers
effect
rate
close
addit
immunoglobulin
expens
approxim
per
gram
antibiot
treatment
target
caus
bacteria
may
yield
great
deal
reliabl
econom
benefit
treatment
kd
detail
pathogen
mechan
diseas
defin
studi
